查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585819

篩檢市場：按技術、產品和最終用戶分類 - 全球預測 2025-2030

Breast Cancer Screening Market by Technology (Ionizing Breast Imaging Technologies, Non-ionizing Breast Imaging Technologies), Product (Accessories, Breast Imaging Systems, Software & Services), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

乳癌篩檢市場2023年估值為50.1億美元，預計2024年將達到53.1億美元，複合年成長率為6.72%，預計到2030年將達到79億美元。

乳癌篩檢涉及旨在在症狀出現之前的早期階段檢測乳癌的醫學測試，主要透過乳房 X 光檢查、超音波和 MRI 等方法。強調乳癌篩檢的必要性，因為早期檢測有可能降低死亡率並提高治療效果。最終用戶主要是40歲以上的女性，但隨著意識的提高，年輕女性也在使用它。主要市場成長要素包括 3D乳房X光攝影和人工智慧增強影像等篩檢技術的進步，以及全球對女性醫療保健意識和措施的提高。此外，新興市場的政府支持政策和改善的醫療基礎設施提供了巨大的成長潛力。然而，挑戰仍然存在，包括獲得醫療保健的機會存在差異，尤其是在低收入地區，以及關於過度診斷和誤報潛在風險的持續爭論，這些風險可能會降低篩檢率。

主要市場統計
基準年[2023] 50.1億美元
預計年份 [2024] 53.1億美元
預測年份 [2030] 79億美元
複合年成長率（%） 6.72%

業務成長的機會在於開發具有成本效益的攜帶式篩檢設備和人工智慧工具，以提高診斷成像的準確性並減少操作時間。透過提高可及性和知名度的策略擴展到開拓的市場可以帶來巨大的回報。研究考慮遺傳因素和生活方式的個人化篩檢方法可能會提高療效和可接受性。在技​​術創新和公共衛生政策的推動下，市場格局是動態的，但必須駕馭監管格局並解決社會經濟障礙。這個市場的性質是高度競爭的，大型醫療保健公司和精品公司透過技術力和策略聯盟爭奪市場佔有率。公司優先投資最尖端科技研發，與政府機構進行策略合作，並積極參與社區推廣計劃，以教育和鼓勵定期健康檢查，以確保整體市場滲透率和永續性。

市場動態：揭示快速發展的乳癌篩檢市場的關鍵市場洞察

供需的動態交互作用正在改變篩檢市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球女性癌症患者數量增加
    • 政府開展健康宣傳活動以提高對該疾病的認知
    • 大規模採用 MRI 技術進行篩檢和監測
  • 市場限制因素
    • 篩檢設備召回
  • 市場機會
    • AI 支援的 3D乳房X光攝影用於癌症篩檢的出現
    • 採用先進的免疫療法
  • 市場挑戰
    • 誤診的潛在風險

波特五力：駕馭篩檢市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解篩檢市場的外部影響

外部宏觀環境因素在塑造篩檢市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解篩檢市場的競爭格局

篩檢市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣乳癌篩檢市場供應商的績效評估

FPNV定位矩陣是評估篩檢市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，規劃篩檢市場的成功之路

篩檢市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地女性癌症病例不斷增加
      • 政府開展健康宣傳活動以提高對該疾病的認知
      • 顯著引入 MRI 技術進行篩檢和監測。
    • 抑制因素
      • 篩檢設備召回
    • 機會
      • 在癌症篩檢中引入人工智慧輔助 3D 乳房 X 光攝影
      • 引進先進免疫療法
    • 任務
      • 結果不正確的可能性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章乳癌篩檢市場：依技術分類

  • 電離乳房攝影技術
    • 3D 乳房斷層合成
    • 模擬乳房X光攝影
    • 錐狀射束電腦斷層掃描 (CBCT)
    • 造影乳房X光攝影（CEM）
    • 全視野數位乳房攝影（FFDM）
    • 分子乳房成像/乳房特異性伽瑪成像 (MBI/BSGI)
    • 正子發射乳房X光攝影（PEM）
    • 正子斷層掃描與電腦斷層掃描 (PET-CT)
  • 非電離乳房攝影技術
    • 自動全乳超音波(AWBU)
    • 乳腺核磁共振檢查
    • 乳房熱成像
    • 乳腺超音波檢查
    • 電電阻掃描
    • 光學成像

第7章乳癌篩檢市場：依產品

  • 配件
  • 乳房攝影系統
  • 軟體和服務

第8章乳癌篩檢市場：依最終用戶分類

  • 乳腺癌護理中心
  • 影像診斷中心
  • 醫院/診所

第9章美洲篩檢市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太乳癌篩檢市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的乳癌篩檢市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AstraZeneca plc
  • Bayer AG
  • Becton, Dickinson and Company
  • Carestream Health, Inc.
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • GlaxoSmithKline plc
  • Hologic, Inc.
  • Koning Health
  • Koninklijke Philips NV
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • NIRAMAI Health Analytix Private Limited
  • Novartis AG
  • Oncocyte Corporation
  • OncoStem Diagnostics Pvt. Ltd
  • Pfizer Inc.
  • Prelude Corporation
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Syantra Inc.
  • Vayyar Imaging, Ltd.
Product Code: MRR-521BAA36EB3C

The Breast Cancer Screening Market was valued at USD 5.01 billion in 2023, expected to reach USD 5.31 billion in 2024, and is projected to grow at a CAGR of 6.72%, to USD 7.90 billion by 2030.

Breast cancer screening involves medical tests designed to detect breast cancer at an early stage before any symptoms appear, primarily through methods like mammograms, ultrasound, and MRI. The necessity of breast cancer screening is underscored by its potential to reduce mortality rates through early detection, which improves treatment efficacy. Its applications span hospitals, diagnostic laboratories, and specialty clinics, with end-use mainly among women aged 40 and above, though increasing accessibility extends these services to younger women due to rising awareness. Key market growth factors include advancements in screening technology, such as 3D mammography and AI-enhanced imaging, along with heightened awareness and female healthcare initiatives globally. Moreover, supportive governmental policies and improved healthcare infrastructure in emerging markets present substantial growth potential. However, challenges remain, including disparities in access to care, particularly in low-income regions, and the ongoing debate about the potential risks of overdiagnosis or false positives, which may undermine screening uptake.

KEY MARKET STATISTICS
Base Year [2023] USD 5.01 billion
Estimated Year [2024] USD 5.31 billion
Forecast Year [2030] USD 7.90 billion
CAGR (%) 6.72%

Opportunities for business growth lie in developing cost-effective, portable screening devices and AI tools that enhance imaging accuracy and reduce operational time. Expansion into untapped markets with tailored strategies to improve accessibility and awareness could yield significant dividends. Research into personalized screening approaches, considering genetic and lifestyle factors, might enhance effectiveness and acceptance. The breast cancer screening market is dynamic, driven by technological innovation and public health policies, but it requires navigating regulatory landscapes and addressing socio-economic barriers. The nature of this market is highly competitive, with established healthcare giants and boutique firms vying for market presence, largely dictated by technological prowess and strategic alliances. Companies are recommended to prioritize investment in R&D for cutting-edge technologies, strategically collaborate with governmental agencies for better reach, and actively engage in community outreach programs to educate and encourage regular screening adherence, ensuring holistic market penetration and sustenance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Cancer Screening Market

The Breast Cancer Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of cancer in women globally
    • Government health campaign to raise disease awareness
    • Significant adoption of MRI techniques for screening and monitoring.
  • Market Restraints
    • Breast cancer screening device recalls
  • Market Opportunities
    • Emergence of AI-supported 3D mammogram screening for cancer screening
    • Adoption of advanced Immunotherapy
  • Market Challenges
    • Potential risk of false results

Porter's Five Forces: A Strategic Tool for Navigating the Breast Cancer Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Cancer Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Cancer Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Cancer Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Cancer Screening Market

A detailed market share analysis in the Breast Cancer Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Cancer Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Cancer Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Cancer Screening Market

A strategic analysis of the Breast Cancer Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Cancer Screening Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca plc, Bayer AG, Becton, Dickinson and Company, Carestream Health, Inc., Danaher Corporation, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., GlaxoSmithKline plc, Hologic, Inc., Koning Health, Koninklijke Philips N.V., Myriad Genetics, Inc., NanoString Technologies, Inc., NIRAMAI Health Analytix Private Limited, Novartis AG, Oncocyte Corporation, OncoStem Diagnostics Pvt. Ltd, Pfizer Inc., Prelude Corporation, Quest Diagnostics Incorporated, Siemens Healthineers AG, Syantra Inc., and Vayyar Imaging, Ltd..

Market Segmentation & Coverage

This research report categorizes the Breast Cancer Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Ionizing Breast Imaging Technologies and Non-ionizing Breast Imaging Technologies. The Ionizing Breast Imaging Technologies is further studied across 3D Breast Tomosynthesis, Analog Mammography, Cone-Beam Computed Tomography (CBCT), Contrast-Enhanced Mammography (CEM), Full-Field Digital Mammography (FFDM), Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI), Positron Emission Mammography (PEM), and Positron Emission Tomography and Computed Tomography (PET-CT). The Non-ionizing Breast Imaging Technologies is further studied across Automated Whole-Breast Ultrasound (AWBU), Breast MRI, Breast Thermography, Breast Ultrasound, Electric Impedance Tomography, and Optical Imaging.
  • Based on Product, market is studied across Accessories, Breast Imaging Systems, and Software & Services.
  • Based on End User, market is studied across Breast Care Centers, Diagnostic Imaging Centers, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of cancer in women globally
      • 5.1.1.2. Government health campaign to raise disease awareness
      • 5.1.1.3. Significant adoption of MRI techniques for screening and monitoring.
    • 5.1.2. Restraints
      • 5.1.2.1. Breast cancer screening device recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of AI-supported 3D mammogram screening for cancer screening
      • 5.1.3.2. Adoption of advanced Immunotherapy
    • 5.1.4. Challenges
      • 5.1.4.1. Potential risk of false results
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Breast Cancer Screening Market, by Technology

  • 6.1. Introduction
  • 6.2. Ionizing Breast Imaging Technologies
    • 6.2.1. 3D Breast Tomosynthesis
    • 6.2.2. Analog Mammography
    • 6.2.3. Cone-Beam Computed Tomography (CBCT)
    • 6.2.4. Contrast-Enhanced Mammography (CEM)
    • 6.2.5. Full-Field Digital Mammography (FFDM)
    • 6.2.6. Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI)
    • 6.2.7. Positron Emission Mammography (PEM)
    • 6.2.8. Positron Emission Tomography and Computed Tomography (PET-CT)
  • 6.3. Non-ionizing Breast Imaging Technologies
    • 6.3.1. Automated Whole-Breast Ultrasound (AWBU)
    • 6.3.2. Breast MRI
    • 6.3.3. Breast Thermography
    • 6.3.4. Breast Ultrasound
    • 6.3.5. Electric Impedance Tomography
    • 6.3.6. Optical Imaging

7. Breast Cancer Screening Market, by Product

  • 7.1. Introduction
  • 7.2. Accessories
  • 7.3. Breast Imaging Systems
  • 7.4. Software & Services

8. Breast Cancer Screening Market, by End User

  • 8.1. Introduction
  • 8.2. Breast Care Centers
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Hospitals & Clinics

9. Americas Breast Cancer Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Breast Cancer Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Breast Cancer Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca plc
  • 2. Bayer AG
  • 3. Becton, Dickinson and Company
  • 4. Carestream Health, Inc.
  • 5. Danaher Corporation
  • 6. Exact Sciences Corporation
  • 7. F. Hoffmann-La Roche Ltd
  • 8. Fujifilm Holdings Corporation
  • 9. GE HealthCare Technologies Inc.
  • 10. GlaxoSmithKline plc
  • 11. Hologic, Inc.
  • 12. Koning Health
  • 13. Koninklijke Philips N.V.
  • 14. Myriad Genetics, Inc.
  • 15. NanoString Technologies, Inc.
  • 16. NIRAMAI Health Analytix Private Limited
  • 17. Novartis AG
  • 18. Oncocyte Corporation
  • 19. OncoStem Diagnostics Pvt. Ltd
  • 20. Pfizer Inc.
  • 21. Prelude Corporation
  • 22. Quest Diagnostics Incorporated
  • 23. Siemens Healthineers AG
  • 24. Syantra Inc.
  • 25. Vayyar Imaging, Ltd.

LIST OF FIGURES

  • FIGURE 1. BREAST CANCER SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. BREAST CANCER SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BREAST CANCER SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BREAST CANCER SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 3D BREAST TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONE-BEAM COMPUTED TOMOGRAPHY (CBCT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONTRAST-ENHANCED MAMMOGRAPHY (CEM), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY FULL-FIELD DIGITAL MAMMOGRAPHY (FFDM), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING/BREAST SPECIFIC GAMMA IMAGING (MBI/BSGI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY POSITRON EMISSION MAMMOGRAPHY (PEM), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST MRI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST THERMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ELECTRIC IMPEDANCE TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 244. BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023